SLN Stock Analysis: Buy, Sell, or Hold?
SLN - Silence Therapeutics Plc American Depository Share
$4.90
0.08 (1.66%)
▲
5d:
-9.76%
30d:
-19.41%
90d:
-32.97%
HOLD
LOW Confidence
Last Updated: February 2, 2026
Earnings: Feb 26, 2026
22d
Get Alerted When SLN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SLN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SLN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SLN is currently trading at $4.90, which is considered oversold relative to its 30-day fair value range of $5.18 to $6.06.
Technical Outlook: Technically, SLN is showing sideways momentum. Immediate support is located at $4.68, while resistance sits at $6.13.
Market Sentiment: SLN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $33.80 (+589.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SLN is showing sideways momentum. Immediate support is located at $4.68, while resistance sits at $6.13.
Market Sentiment: SLN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $33.80 (+589.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$5.18 -
$6.06
Company Quality Score
50/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
60.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 589.8% below Wall St target ($33.80)
- CAUTION: Recommendation downgraded due to -9.8% 5-day decline
Fair Price Analysis
30-Day Fair Range
$5.18 -
$6.06
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.89
(18.1%)
Support & Resistance Levels
Support Level
$4.69
Resistance Level
$6.13
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
-5.44
Wall Street Target
$33.80
(+589.8%)
Revenue Growth (YoY)
-89.4%
Profit Margin
-249.9%
Last updated: February 03, 2026 2:36 AM ET
Data refreshes hourly during market hours. Next update: 3:36 AM
Data refreshes hourly during market hours. Next update: 3:36 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 58 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 60 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 55 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$34 | 51 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 60 HOLD |
